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Abstract
Background: ePrescribing systems have significant potential to improve the safety and efficiency of healthcare, but they
need to be carefully selected and implemented to maximise benefits. Implementations in English hospitals are in the early
stages and there is a lack of standards guiding the procurement, functional specifications, and expected benefits. We
sought to provide an updated overview of the current picture in relation to implementation of ePrescribing systems,
explore existing strategies, and identify early lessons learned.
Methods: A descriptive questionnaire-based study, which included closed and free text questions and involved both
quantitative and qualitative analysis of the data generated.
Results: We obtained responses from 85 of 108 NHS staff (78.7% response rate). At least 6% (n = 10) of the 168 English NHS
Trusts have already implemented ePrescribing systems, 2% (n = 4) have no plans of implementing, and 34% (n = 55) are
planning to implement with intended rapid implementation timelines driven by high expectations surrounding improved
safety and efficiency of care. The majority are unclear as to which system to choose, but integration with existing systems
and sophisticated decision support functionality are important decisive factors. Participants highlighted the need for
increased guidance in relation to implementation strategy, system choice and standards, as well as the need for top-level
management support to adequately resource the project. Although some early benefits were reported by hospitals that had
already implemented, the hoped for benefits relating to improved efficiency and cost-savings remain elusive due to a lack
of system maturity.
Conclusions: Whilst few have begun implementation, there is considerable interest in ePrescribing systems with ambitious
timelines amongst those hospitals that are planning implementations. In order to ensure maximum chances of realising
benefits, there is a need for increased guidance in relation to implementation strategy, system choice and standards, as well
as increased financial resources to fund local activities.
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Introduction
A number of international benchmark studies have demon-
strated that prescribing errors are common and are responsible for
considerable – potentially avoidable – morbidity and mortality [1–
3]. Given the increasing complexity of prescribing decisions, the
risk of prescribing-related iatrogenic harm is likely to increase yet
further. Improving the quality and safety of prescribing, as well as
optimising the use of medicines throughout the health sector is
therefore now firmly established as a priority area throughout
much of the economically-developed world, including the United
Kingdom (UK). Electronic prescribing (or ePrescribing) is seen as
one way to help deliver on this priority issue.
ePrescribing systems involve ‘‘the utilisation of electronic systems to
facilitate and enhance the communication of a prescription or medicine order,
aiding the choice, administration and supply of a medicine through knowledge
and decision support and providing a robust audit trail for the entire medicines
use process’’ [4]. As such, although systems vary in sophistication,
they can amongst other things help to prevent duplicate
prescribing, minimise the risk of contraindicated prescribing (e.g.
due to drug-drug interactions), reduce dosing errors, support more
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cost effective prescribing, and facilitate adherence to formulary-
based recommendations [5–11].
However, realising these benefits is far from straightforward.
This is particularly true for UK hospitals, where ePrescribing
systems are to date not routinely used. These technologies can
initially be extremely disruptive, changing established ways of
working and patients’ experiences of care [12,13]. They can
furthermore result in unintended consequences, which may
include new kinds of error and thus potential threats to patient
safety. Koppel and colleagues, for example, reported how
fragmented basic ePrescribing system displays prevented a
coherent view of patients’ medication and how the separation of
functions facilitated double dosing [14]. Similarly, it has been
found that many systems can produce clinically spurious alerts
[15,16]. This frustrates end-users and result in alerts commonly
being over-ridden or ignored. More recent work has highlighted
potentially serious treatment delays that can inadvertently be
associated with the introduction of ‘hard stops’ to reduce risk of
serious prescribing errors [17,18]. It is therefore important that
such systems are carefully selected and implemented to maximise
the likelihood of benefit to patients. However, existing technologies
vary considerably in functionality, level of inter-operability and
costs. The variety of systems and stakeholders involved compli-
cates organisational decision making regarding the choice of
system and implementation strategies. This is further compounded
by a lack of standards guiding the procurement, functional
specifications, expected benefits and strategies for implementation
of these systems [19,20].
The UK context is unusual as there were previous attempts to
introduce national health information systems through the
National Programme for Information Technology (NPfIT),
characterised by a centrally-led procurement and implementation
model of selected software systems (that were subsidised by central
resources) [21,22]. The strategic direction has, however, recently
changed to allow increased input of local organisations in decision
making, which means that healthcare organisations are now faced
with a wider range of choices and may lack central direction
relating to procurement and implementation of systems [21,22].
Although ePrescribing systems are very well established in UK
primary care, the transfer of electronic data between hospitals and
primary care settings is to date limited [15,19,23,24]. The major
primary care systems in the UK are EMIS, Vision, TPP
SystmOne and GPASS [23,24], the ePrescribing functionality
being an integral feature of the electronic health record system.
To inform our on-going national evaluation of the introduction
of ePrescribing systems into English National Health Service
(NHS) hospitals, and building on previous work that reported
considerable interest in investing in ePrescribing systems [20,25],
we undertook a scoping study in which we sought to: 1) provide an
updated overview of the current picture in relation to implemen-
tation of ePrescribing systems; 2) explore existing implementation
strategies; and 3) identify early lessons learned.
Materials and Methods
Ethical Considerations
This work is part of a national service evaluation investigating
the implementation and adoption of ePrescribing systems in
English hospitals [25]. Participants gave verbal informed consent
to participate.
Design and Questionnaire Development
We undertook a questionnaire-based descriptive study with a
combination of closed and free text questions, which involved
both quantitative and qualitative analysis of the data generated.
The design of our questionnaire was informed by the existing
literature surrounding information technology (IT) implementa-
tions in healthcare settings [8,13,26–29], our own experiences
from implementing and evaluating related applications [20,25],
and a questionnaire from a scoping study of planned
implementations conducted in 2010 [20]. We devised a range
of structured and semi-structured questions enquiring about
participant demographics, system functionality and anticipated
implementation timelines. In addition, we included a range of
open-ended questions relating to implementation strategies,
anticipated changes, and lessons learned to date. A full version
of the questionnaire can be viewed in Figure S1. Iterative
development and piloting with clinical and academic colleagues,
allowed refinement of the included items over a period of two
months. This resulted in changes to the ordering of items and
phrasing of some questions.
Distribution of the Questionnaire
As with our previous study, questionnaires were included in the
delegate packs of attendees at a national conference on the
implementation of ePrescribing systems into English NHS
hospitals hosted by the research team in March 2012. The
conference aimed to provide a national platform for networking of
interested parties and discussion of experiences to date [25].
Delegates included 150 representatives from a range of NHS
Trusts, system suppliers, and academic institutions. All attending
NHS staff (n = 108) were encouraged to complete the question-
naire in a designated slot during the opening session of the
conference. Completed forms were collected by the research team
before delegates left this session.
Data Handling and Analysis
Questionnaires were numbered consecutively and numerical,
categorical and qualitative data were entered in a Microsoft
Access database. Categorical and numerical data relating to
participant demographics, system characteristics and capabilities
(Section 1 and the first four items of Section 2, see Figure S1)
were then exported into Microsoft Excel to calculate descriptive
statistics. Qualitative data surrounding implementation strate-
gies, anticipated changes and lessons learned (the remainder of
items in Section 2 and Section 3, see Figure S1) were exported
into NVivo9 software [30]. Qualitative data were initially coded
against headings of the questionnaire, followed by cross-sectional
coding to extract cross-cutting themes [31]. This resulted in four
overarching themes with corresponding sub-themes. These were
chosen based on frequency of occurrence (i.e. mentioned by a
large number of participants), and on the basis of significance
(i.e. helping to explore underlying tensions).
Results
The following paragraphs will explore both the quantitative and
qualitative results in more detail. For these purposes, we have
divided the results into two sections. We first report on quantitative
data including participant demographics, numbers of planned/on-
going implementations, and specified systems functionality. We
then explore more cross-cutting themes extracted in the qualitative
analysis relating to implementation strategies and early lessons
learned.
We obtained responses from 85/108 NHS staff resulting in a
response rate of 79% (Figure 1). Respondents came from a total of
55 different English NHS Trusts (out of a total of 168 throughout
England, a Trust is a public sector organisation providing local
ePrescribing Systems in NHS Hospitals
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services, there are 168 Trusts in the English NHS) and these
comprised of: 47 Acute (hospital) Trusts (representing 85% of the
total of Acute Trusts); seven Mental Health Trusts (representing
13%), and one Community Trust (representing 2%). Responses
from the same Trust were combined to avoid double-counting.
The majority of respondents (n = 53, 62%) were pharmacists.
They tended to be in senior positions such as Heads of Medicines
Management, Chief Pharmacists, and ePrescribing Leads. The
remainder included Managers (n = 22, 26%), Consultant (medical)
Clinical Leads (n = 6, 7%), and Nurse Leads (n = 4, 5%).
Planned/on-going Implementations, and Systems
Functionality
Implementation of ePrescribing systems. Out of the 55
Trusts, 30 (55%) were planning to implement or in the process of
procuring a system, 11 (20%) were currently implementing, 10
(18%) had already implemented, and four (7%) had no current
plans of implementing an ePrescribing system (Table 1 and
Figure 1).
Of those that were currently implementing or had started
procurement, the majority had or were expecting to initiate the
process between 2008 and 2014 (median: 2012) and expected to
finish between 2012 and 2019 (median: 2014). Trusts that had
already implemented began between 1999 and 2009 (median:
2009) and finished between 2007 and 2012 (median: 2011).
The range of different systems implemented or planned to be
implemented was relatively large and is summarised in Table 1.
JAC had the largest number of completed implementations in four
out of 10 Trusts (40%). Cerner was in the process of being
implemented in two out of 11 Trusts (18%).
System functionality. In terms of system functionality
provided or expected to be provided, 82% (n= 45) of Trusts
indicated that they had or were planning to implement decision
support functionality, 80% (n= 44) indicated computerised links to
other patient care records functionality, 71% (n= 39) indicated
knowledge support functionality, 67% (n= 37) computerised links
to test laboratory results, and 55% (n= 30) computerised links to
pharmacy systems (see Figure 2).
Implementation Strategies and Early Lessons Learned
This section is divided into four themes and corresponding sub-
themes emerging from the data. These will be discussed in turn
and are summarised in Table 2 with illustrative quotes from
participants. Although a range of issues were identified, many of
these were common to different types of IT implementations in
healthcare settings and are relatively well-known throughout the
literature. [8,13,26–29] We will therefore focus on outlining those
that are particularly relevant to ePrescribing systems implemen-
tations:
N Strategic planning and testing of potential impact
N Engagement and buy-in of different staff groups
N Systems choice and desired functionality
N Top-level buy-in and management.
Strategic planning and testing of potential
impact. Trusts that were planning to implement or in the
process of procuring an ePrescribing system, expected to begin
implementation in 2012 with an anticipated three to five year roll-
out period. Between one and four wards were estimated to ‘go live’
(i.e. switch on the system) every two to four weeks. The underlying
reasons for the nature of these roll-outs were attempts to minimise
perceived safety risks surrounding the running of parallel paper
and electronic systems in the same institution. Pilot implementa-
tions and extensive testing before larger-scale roll-out were viewed
as important to identify and manage problems in a contained
setting and predict the impact of new software and hardware on
user workflows.
Most Trusts intended to begin with basic functionality (e.g. to-
take-out medication), followed by roll-out across linked specialties,
and implementation of more complex functionality (e.g. intrave-
nous prescribing and other bespoke prescriptions such as sliding
scale insulin). The most popular initial implementations were
planned to be in elderly care and surgical wards, oncology, and
outpatient settings. Underlying reasons for focusing on these areas
included either that these were viewed as highly complex (i.e. it
was assumed that if the system would work in these settings then it
would be ‘easier’ to implement in the rest of the Trust), or as
relatively ‘simple’ (i.e. they were used to identify problems before
implementing in more complex settings). These may be perceived
as contradictory arguments, which perhaps implies that partici-
pants recognised the possible challenges of implementation, but
that there was no obvious case perceived across the sample for
choosing one strategy over the other.
Figure 1. Flowchart illustrating numbers of participants, implementation status and systems.
doi:10.1371/journal.pone.0053369.g001
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Despite these short implementation timelines, many participants
reporting on their experiences of having implemented a system
cautioned that the setting of realistic timeframes was important,
illustrated by written statements such as ‘‘don’t rush it, takes time to do
it properly’’ (Participant 7, Pharmacist) or ‘‘don’t underestimate the time it
will take’’ (Participant 19, Pharmacist). A specific area mentioned as
an example included configuration and management of the
underlying drug database, where participants indicated that ‘‘lots
of prep time to build drug file etc. is beneficial later on’’ (Participant 64,
Pharmacist).
Engagement and buy-in of different staff groups. Due to
the variety of professions using ePrescribing systems (i.e. clinicians
including junior doctors, pharmacists, nurses), engaging different
staff groups as early in the process as possible, preferably in
relation to systems choice, was viewed as crucial, although often
not realised:
‘‘Most systems lack clinical input and yet clinicians are expected to use
systems and have little choice in system chosen.’’ (Participant 18,
Pharmacist)
An important constraint here was the difficulty of releasing staff
from clinical duties to allow involvement in decision making:
‘‘…’clinical buy in’ has been difficult as time to attend demos is
constrained by NHS commitments/activity i.e. medical and pharmacy
staff cannot be released to attend lengthy seminars when they have
clinics, theatre lists and ward rounds. Danger is final decision made by
staff who may not be front end users.’’ (Participant 3, Pharmacist)
Clinical champions were viewed as important to engage senior
medical staff, but participants stated that some staff groups tend to
be neglected, resulting in a lack of engagement. This was
Table 1. Implemented and plans to implement ePrescribing systems and system types in 55 NHS Trusts.
Already implemented
(10 different Trusts)
Currently implementing
(11 different Trusts)
Planning to implement/procuring
(34 different Trusts)
4 JAC 2 Cerner 27 don’t know
1 Cerner 2 iCM 1 System C - CIS Chemocare
1 iCM 1 Galileo 1 Soarian Siemans Health
1 LastWord 1 JAC 1 Cerner
1 Mosaiq (Oncology) 1 MedChart 1 NWIS (built in-house)
1 PICS (built in-house) 1 System C 1 Ascribe
1 RiO 1 RiO 1 Ascribe or JAC
1 TPP 1 Ascribe or RiO
1 don’t know
doi:10.1371/journal.pone.0053369.t001
Figure 2. Graphical presentation of ePrescribing system functionality provided or expected to be provided.
doi:10.1371/journal.pone.0053369.g002
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Table 2. Emerging themes and sub-themes from qualitative analysis of free text responses.
Themes Sub-themes Selected illustrative quotes and issues raised
Strategic planning
and testing of
potential impact
Implementation strategy Often pilots and evaluations on selected wards before larger-scale roll-out (3–6 months prior),
specialty areas often implement separately e.g. chemotherapy. Many implement as quickly as
possible in one ward at a time (e.g. inpatients: between 1 and 4 wards every 2 to 4 weeks, most
report planning to roll out in a year to implement in a medium to large hospital) to avoid
running parallel paper and electronic systems as this is seen as risky. Throughout Trust
(inpatient and outpatient) including full functionality, pilots and preparation: 3–5 years
implementation average (from business case approval to full roll-out). The general strategy is to
implement according to type of wards/specialty and roll-out across linked areas, many
implement in specialty areas last. Most do inpatients first, then Accident and Emergency and
outpatients, but some outpatients first as highest risk area. The tendency is to begin with
simple functionality (e.g. to-take-out medication), roll this out and then add the more complex
functionality (e.g. intravenous prescribing and medicines administration, other bespoke
prescriptions e.g. sliding scale insulin) through system upgrades. Specialties first to implement:
elderly care ward, oncology, outpatients, surgical ward.
Piloting and testing ‘‘More testing/establishment of information and communication technology equipment’’
‘‘Scope everything very thoroughly before making roll out decisions’’
Realistic timeframes ‘‘Timescales difficult to achieve - set realistic ones’’
Configuration and management of
drug database
‘‘Lots of prep time to build drug file etc. is beneficial later on’’
IT support and training ‘‘Understanding implementation support required’’
An integrated strategy ‘‘Have a Trust strategy for all ePrescribing first’’
IT infrastructure ‘‘Ensure IT infrastructure up to the job.’’
Engagement and buy-in
of different staff groups
Different training needs/styles for
different groups
Releasing staff from clinical duties
to allow involvement in
decision making
‘‘Too early except to say that "clinical buy in" has been difficult as time to attend demos is
constrained by NHS commitments/activity i.e. medical and pharmacy staff cannot be released to
attend lengthy seminars when the have clinics, theatre lists and ward rounds. Danger is final
decision made by staff who may not be front end users.’’
Lack of clinical input in systems
choice (including hardware) and
business case
‘‘Consensus is important amongst clinicians prior to beginning procurement’’
Clinical champions ‘‘Medical and clinical leads to drive implementation and deployment.’’
Lack of engagement from nurses ‘‘Work had to engage nurses who are reluctant to engage.’’
Maintaining momentum in
engagement
‘‘Using an extended team of clinicians and specialities was successful, but have now lost interest
and need to re-energise’’
Systems choice and
desired functionality
Need for standards ‘‘Need a clear criteria of functionality this is a must and which is evidence based.’’
Interface design ‘‘Our focus is to use lean principles to drive quality. Hence less emphasis on barriers, restrictions,
huge audit trail datasets. Instead focus on visibility, continuous information flow, measuring only
sufficient data to deliver the message required! Hence design of interface is fundamental to safety
and effectiveness.’’
Support for mobile working ‘‘Most systems do not address mobile working and working in community which is important in
mental health Trust and community areas.’’
Realism - a perfect system does
not exist
‘‘No system has all the answers - allow time for their developments’’
Integration with existing systems ‘‘Good integration with other systems or integrated systems very important’’
Desired functionality (Better) integration with other local systems used across services (e.g. pathology, pharmacy,
stock control) and primary care systems. Improved decision support functionality (e.g.
intelligent alerting to prevent alert fatigue, including dose range checks, linked to clinical roles,
support for infusions, adverse drug reaction and allergy checking, warfarin dosing algorithm,
fluid therapy management, sliding scale insulin monitoring and adjustment). Good reporting
and audit functionality. More intuitive user interface. System to be able to handle more
complex medications and prescribing infusions, batch prescribing. Wireless and mobile
working.
System must meet individual
organisational needs
‘‘Select a system that meets organisation needs (not necessarily part of a national programme)’’
Systems choice is limited to
companies who chose to bid
‘‘Limited by those who choose to those companies who choose to bid.’’
System needs to be developed to a
certain degree
‘‘Can’t wait for Lorenzo!’’
Relationship with supplier ‘‘Specify the characteristics of the relationship with the supplier in the output based specifications.’’
Top-level buy-in and
management
To adequately resource the project ‘‘Need resources to be able to utilise/roll out safely’’
ePrescribing Systems in NHS Hospitals
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particularly true in relation to the most frequent users of the
system including nurses and junior doctors.
Systems choice and desired functionality. The range of
systems available, with different functionalities and of varying cost,
resulted in a perceived need for criteria of functionality and
technical standards to guide systems choice for Trusts:
‘‘In my journey so far it is very important to determine a clear set of
criteria which all systems must comply with. This is huge problem.’’
(Participant 18, Pharmacist)
Many participants also cautioned that an optimal system
fulfilling requirements of all users and implementers was: 1)
unlikely to exist; and 2) unlikely to be useful as ‘‘…a system that does
everything will possibly be a jack of all trades, master of none.’’ (Participant
19, Pharmacist) Most existing systems were also seen as needing
incremental development to suit the needs of hospitals, although
some degree of maturity before procurement was viewed as
necessary. As one respondent noted:
‘‘Don’t buy a product that is not developed yet (or even close to it)’’
(Participant 60, Pharmacist)
Several desirable system functionalities were identified, includ-
ing above all, the ability to interface with other local systems.
‘‘Pharmacy would like to see as much integration into other systems as
possible - simple transformation of electronic drug charts to discharges
and interfacing with pharmacy dispensing systems.’’ (Participant 30,
Pharmacist)
The desired functionality in relation to interfacing also included
seamless integration with primary care systems: ‘‘Seamless
integration with primary care prescribing, populating a single
patient medication record that records what has been issued as
well as prescribed.’’ (Participant 7, Pharmacist).
Many existing technologies lacked the functionalities and were
viewed as too immature. This was also expressed in the hope for
improved sophistication of decision support functionality, both in
relation to handling a wider range of prescribing scenarios and in
terms of preventing alert fatigue: ‘‘More "less" decision support! i.e. more
helpful but less frequent alerts’’. (Participant 61, Pharmacist).
Other desired functionalities included improved user interfaces,
better support for wireless and mobile working (especially in
community settings), and better reporting and audit functionality.
Despite the importance of systems choice, some participants
mentioned that ‘‘the relationship/culture of the supplier is even more
important than the product’’. (Participant 20, Consultant Clinical Lead)
This related to the on-going communication of user needs and the
supplier’s response in terms of system development characterised
by two-way communication channels between Trusts and
suppliers.
‘‘Ensure at procurement to re-communication channels and ethos/stance
on development direction’’ (Participant 27, Manager)
The product specifications and the nature of the relationship
with the supplier (including input in system development) set out at
the procurement stage and determined within the contract were
stated to be important to achieve this.
Table 2. Cont.
Themes Sub-themes Selected illustrative quotes and issues raised
Cost-effectiveness and benefits
realisation (evidence based)
‘‘There is no data out there demonstrating cost releasing savings - a key pillar for a successful
business case’’
Managing expectations whilst
having a vision
‘‘Be optimistic - but realistic! Don’t be disheartened by pauses and challenges’’
Benefits Benefits hoped for: reduced prescribing/medication errors; greater efficiency in relation to
medicines management processes (including discharge) and resulting time savings for staff and
patients; improved patient safety; reduced cost (through better compliance with formularies
and more streamlined processes); improved availability of data for audit and reporting;
improved communication (across teams and over geographical distances) and more integrated
medicines management process; reduction in medication administration errors and improved
timeliness of administration; reduction in transcription errors and improved legibility; better
audit trail; better accessibility of information; reduction in different charts used and paper;
greater compliance with guidelines and pathways.
Current benefits seen by those that have implemented or are in process of implementing:
reduced medication prescribing errors; improved availability of data for audit; improved
availability of information (e.g. no lost drug charts); improved alerts facilitating clinical decision
making; improved adherence to guidelines; improved safety; mobile working; reduced
medication administration errors and missed doses; improved communication between
different departments; improved formulary support; improved legibility.
Disbenefits Workflow changes, increase in certain types of errors, time consuming for doctors and
pharmacists.
Flexibility in strategy ‘‘Flexibility versus structure’’
Adequately sized project teams Many mentioned that their management teams were too small and they found out at roll-out
stage.
Sharing lessons learned ‘‘We are in the process of building the case for ePrescribing so hope to learn from others and their
experiences in this area.’’
doi:10.1371/journal.pone.0053369.t002
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‘‘Software companies need things to be specified in the contract if you
want them delivered. Tie up your contract tightly.’’ (Participant 61,
Pharmacist)
Top-level buy-in and management. Senior buy-in from
hospital managers was described as being essential to ensure
adequate project resourcing and safe implementation. The high
costs of ePrescribing implementation and a lack of resources,
including management teams that were often seen as being too
small, were a concern to many participants.
‘‘Concerns - raising awareness of true resources to implement, manpower
needed to optimise system use, interpret clinical/visit information
potential of the system’’ (Participant 9, Pharmacist)
‘‘Within a district general hospital the cost of implementation is
relatively high. I feel it’s difficult for us to go to the board for funding.
How can smaller hospitals keep up?’’ (Participant 30, Pharmacist)
Once funded, managing expectations whilst keeping the aim in
sight was viewed as essential. Participants stated that stakeholder
expectations of ePrescribing systems were often higher than what
was realistically achievable and that this needed to be communi-
cated to all stakeholders involved, including senior management.
‘‘Manage expectations - people expect far more than EP [ePrescrib-
ing] can deliver’’ (Participant 61, Pharmacist)
‘‘Expectations are high but reality is lower’’ (Participant 65,
Pharmacist)
‘‘Executive directors believe it will save money as no spare money for
system - it must pay for itself. Need to tackle these fanciful ideas early
on. Exec directors think it will do everything.’’ (Participant 66,
Pharmacist)
However, expectation management was seen to be complicated
by the fact that data on cost-effectiveness and benefits realisation
of systems was lacking. Such data were also often needed for
developing a business case.
‘‘Data on benefits realisation/cost-effectiveness seems to be the main
requirement for our finance team (as we put a business case together)
rather than patient focus/patient safety.’’ (Participant 41, Phar-
macist)
‘‘There is no data out there demonstrating cost releasing savings - a key
pillar for a successful business case’’ (Participant 65, Pharmacist)
In terms of benefits, participants hoped for reduced errors,
improved safety, greater efficiency and reduced cost. Benefits
observed by those that had implemented ePrescribing included
reduced errors, improved availability of data for audit, and fewer
lost drug charts. However, Trusts that had already begun
implementation also reported some adverse consequences, partic-
ularly in relation to workflows (which became more linear and less
flexible), the introduction of other types of errors that were not
present before the implementation, and the often time-consuming
nature of system operation.
‘‘Change in type of errors occurring - not a lowering in error rate’’
(Participant 61, Pharmacist)
‘‘Saving time? Too early to say’’ ‘‘Interestingly, drug rounds are taking
longer so no efficiency seen as yet’’ (Participant 25, Nurse Lead)
To address such unanticipated issues, persistence and flexibility
in strategies on part of the management team was viewed as
essential.
‘‘Persist, persist, persist! (Be willing to try different approaches)’’
(Participant 36, Pharmacist)
Discussion
Summary of Main Findings
Our work indicates that, whilst few have begun implemen-
tation, many English Acute and Mental Health NHS Trusts are
planning to implement ePrescribing systems with ambitious
implementation timelines over the next three to five years. This
is despite the apparent need, highlighted by those who have
begun implementation, to allow sufficient time for piloting and
testing, and to set more realistic timeframes. Although many
Trusts are currently in the procurement stages, the majority
were still unclear as to which system to choose. Amongst those
that had a specific system in mind, the underlying reason was
that the Trust had already implemented a system from the same
supplier, which they hoped would facilitate integration with
other systems and help to build on an established relationship
with respective suppliers.
Many respondents highlighted the need for increased guidance
in relation to implementation strategy, system choice and
standards, as well as additional financial resources to fund local
activities to support safe implementation. Whilst advocating
realism in relation to system capabilities, desired functionalities
included integration with existing local and primary care systems
as well as more sophisticated decision support. Although some
early benefits in relation to reduction of errors were realised in sites
that had already implemented, the anticipated benefits relating to
improved efficiency and cost-savings remain elusive.
Strengths and Limitations of this Work
Our scoping study provides an overview of progress and plans to
implement ePrescribing systems into English NHS hospitals as well
as an insight into expectations and early lessons learned. The
nature of the work, combining numerical, categorical and free-text
entries, allowed an insight into progress and plans that may be
extrapolated to a larger population, as well as providing an insight
into underlying reasons and likely barriers that may inhibit
progress in the future.
Participants came from 34% (55 of 168) of English Acute
Trusts and represented a large range of geographical areas and
demographics. Our results are likely to be broadly transferable
to other Trusts, but inferences have to be made with caution as
the majority of managers and pharmacists who attended the
conference were interested in implementing ePrescribing sys-
tems. It is therefore likely that, as a result of drawing on a
convenience sample, there may be lower interest in implement-
ing ePrescribing systems in non-participating Trusts. Neverthe-
less, based on the number of Trusts represented, the numbers
are substantial.
A further limitation relates to the design of our questionnaire,
which was deliberately kept as short as possible to maximise the
chances of it being successfully completed. This however meant we
were not able to probe issues in detail and hence were unable to
distinguish between current and future implementation–related
activities.
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Considering our Findings in the Light of the Current
Implementation Landscape
Two years after our first survey of planned implementations of
ePrescribing systems in English hospitals [20], our current work
has confirmed the increasing activity surrounding procurement
and implementation with 55% of Trusts planning to implement
and 20% currently implementing a system (total: 75%). These
numbers are comparable to the 82% of Trusts who were either
planning to implement or in the process of implementing an
ePrescribing system in our initial survey, and an increase in
ePrescribing system implementations internationally [32]. How-
ever, despite the remaining interest and activity, we can observe
an increasing uncertainty in relation to systems choice reflected in
the large number of different systems being actively considered.
This may be due to the immaturity of existing systems, and lack
of high-level strategic leadership demonstrated in our current
work. Other countries have taken a different approach to
implementation, which might address these issues to some extent.
For example, the United States of America is promoting the
principle of Meaningful Use, encouraging healthcare organisa-
tions to implement and adopt systems that fulfil national
standards with the help of financial incentives [33,34]. This
approach is more likely to lead to competition amongst
commercial providers, resulting in a ‘‘pool’’ of accredited systems
that organisations can chose from whilst still having some element
of autonomy in relation to functionality.
In the UK, it is now important that system suppliers and NHS
stakeholders work together to develop existing systems further as
these are currently relatively immature in English hospital settings
[35]. Expectations are high particularly in relation to the inclusion
of sophisticated decision support functionalities and interoperabil-
ity with existing systems, as this is likely to ensure that technologies
are effectively adopted and utilised to derive maximum benefits.
However, unrealistic expectations surrounding the capabilities of
systems may inadvertently result in disappointment and disillu-
sioned stakeholders when faced with systems that are performing
in ways other than desired [21,36]. Such functionality already
exists in international centres of excellence but requires extensive
customisation [37,38], which is relatively difficult to achieve with
commercial systems as these need to satisfy a large range of needs.
Building relationships with suppliers will be essential in order to
achieve anticipated returns on investment and necessitates a
careful balancing act between a system that suits individual settings
and a solution that is commercially viable. Paradoxically,
customisation is likely to result in trade-offs surrounding system
maintenance and interoperability: the fact that a large range of
different ePrescribing systems are available and planned to be
implemented nationally could compromise exchange of informa-
tion between systems [39]. This phenomenon is well-known in
other organisational settings and existing work indicates that a
certain degree of integration of local systems may nevertheless be
possible [40].
Overall, although advocated by many in the past [41,42], more
realism is still needed in relation to implementing information
technologies in health service organisations. ePrescribing system
implementations are still in their infancy and despite some early
benefits, systems necessarily have some drawbacks that need to be
accommodated. It is of concern that implementing Trusts have
reported the introduction of new errors, but this could be
addressed by sharing lessons learned surrounding perceived
short-comings and likely risks of different types of systems. This
could then help Trusts that have yet to implement to plan for these
in advance.
Planned timelines of Trusts yet to implement seem, in the light
of limited resources and lack of demonstrated efficiency savings,
to be perhaps rather ambitious. This is despite those with
experience calling for more thorough planning and testing
activity, which is by definition time-consuming. This is compli-
cated by the fact that there is still limited knowledge surrounding
the parallel running of paper and electronic systems both in
practice and in the published literature [13,21,43]. However, our
work has shown that parallel systems are a concern for many and
an underlying reason for pushing implementations forward.
Overall, the concern that paper and electronic systems used in
parallel result in increased threats to patient safety may need to
be secondary, when to considering the potential risks associated
with rushed implementation timelines.
Implications for Policy, Practice and Future Research
Our work has shown that there is a widespread recognition that
ePrescribing systems have significant potential in improving the
safety and quality of care and hence many Trusts are actively
planning or pursuing implementation. However, with the demise
of the NPfIT [21,22], Trusts are now facing the choice amongst
various systems with differing capabilities and costs, whilst lacking
central guidance in relation to system standards and implemen-
tation strategies. The need for a central body facilitating the
development of systems according to standards ensuring usability
and interoperability is therefore apparent.
The present work is intended as a starting point of the journey
to more widely implement ePrescribing in English NHS hospitals.
We have recently commenced working on a national evaluation of
ePrescribing systems in English hospitals, which aims to provide
Trusts with an implementation toolkit and guidance in relation to
systems choice [25]. In doing so, we plan to track developments
over a period of five years and attempt to estimate the effectiveness
and cost-effectiveness of various systems. However, our work is
limited in time and resources and it is now important that longer-
term strategies are developed to tackle the issue surrounding
higher-level leadership.
In terms of research, our work suggests that there is an urgent
need to examine the use of parallel electronic and paper systems as
the perceived risks associated with this seem to drive ambitious
implementation timelines. As a result, some effective ways to tackle
parallel systems use may be devised, or it may be discovered that
concerns are unfounded and timelines can be relaxed as a result.
Conclusions
The majority of English Acute NHS Trusts in our sample are
still in the process of planning to implement ePrescribing systems
in the forthcoming years with fast-paced roll-outs, driven by high
expectations surrounding improved safety and efficiency of care.
However, the large range of existing systems, the lack of standards
surrounding systems choice, restricted funding due to unclear
return on investment, and the immaturity of existing systems has
left many Trusts uncertain as to how to approach systems
procurement.
Interoperability with existing systems and sophisticated decision
support functionality are likely to increase the appeal of existing
ePrescribing systems to Trusts, but these require a careful
balancing act between customisation and setting of standards to
allow exchange of information. In order to achieve this, a more
integrated approach to sharing lessons and experiences is needed
to help ensure that unanticipated issues can be planned for in
advance and that ePrescribing systems fulfil the promise of safer
medicines management in hospitals.
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Supporting Information
Figure S1 Sample questionnaire - plans to and experi-
ences of implementing ePrescribing systems in your
hospital.
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